Thomas Wilke1. 1. Institute for Pharmacoeconomics and Drug Logistics, University of Wismar, Wismar, Germany.
Abstract
BACKGROUND: Since 2008, the availability of the oral direct thrombin inhibitor dabigatran etexilate provides a further therapeutic alternative to injectable low-molecular-weight heparin (LMWH) for thromboprophylaxis following hip or knee replacement surgery. The intention of this study is to analyze patient preferences for this new oral thromboprophylaxis agent. METHODS: Face-to-face interviews were conducted with 73 doctors and nurses in 12 German hospitals, 195 current hip and knee replacement patients in six German rehabilitation hospitals, and 202 former thromboprophylaxis patients. Qualitative questions were complemented by a full-profile ranking-based conjoint analysis regarding alternative thromboprophylaxis regimens. RESULTS: Nearly 100% of the interviewed medical staff viewed the daily subcutaneous LMWH injection as a source of inconvenience for patients. However, both current and former patients perceived their discomfort to be much less intense. In contrast, the conjoint estimates of preferences showed that older and male patients in particular understated their levels of discomfort in a face-to-face interview situation and had a strong preference for oral anticoagulation. CONCLUSIONS: Patients in Germany appear to have a positive preference for oral thromboprophylaxis after major orthopedic surgery.
BACKGROUND: Since 2008, the availability of the oral direct thrombin inhibitor dabigatran etexilate provides a further therapeutic alternative to injectable low-molecular-weight heparin (LMWH) for thromboprophylaxis following hip or knee replacement surgery. The intention of this study is to analyze patient preferences for this new oral thromboprophylaxis agent. METHODS: Face-to-face interviews were conducted with 73 doctors and nurses in 12 German hospitals, 195 current hip and knee replacement patients in six German rehabilitation hospitals, and 202 former thromboprophylaxis patients. Qualitative questions were complemented by a full-profile ranking-based conjoint analysis regarding alternative thromboprophylaxis regimens. RESULTS: Nearly 100% of the interviewed medical staff viewed the daily subcutaneous LMWH injection as a source of inconvenience for patients. However, both current and former patients perceived their discomfort to be much less intense. In contrast, the conjoint estimates of preferences showed that older and male patients in particular understated their levels of discomfort in a face-to-face interview situation and had a strong preference for oral anticoagulation. CONCLUSIONS:Patients in Germany appear to have a positive preference for oral thromboprophylaxis after major orthopedic surgery.
Authors: H Van Aken; C Bode; H Darius; C Diehm; A Encke; D C Gulba; S Haas; W Hacke; W Puhl; M Quante; H Riess; R Scharf; S Schellong; T Schrör; K L Schulte; U Tebbe Journal: Clin Appl Thromb Hemost Date: 2001-07 Impact factor: 2.389
Authors: B I Eriksson; O E Dahl; H R Büller; R Hettiarachchi; N Rosencher; M-L Bravo; L Ahnfelt; F Piovella; J Stangier; P Kälebo; P Reilly Journal: J Thromb Haemost Date: 2005-01 Impact factor: 5.824
Authors: William H Geerts; Graham F Pineo; John A Heit; David Bergqvist; Michael R Lassen; Clifford W Colwell; Joel G Ray Journal: Chest Date: 2004-09 Impact factor: 9.410
Authors: Bengt I Eriksson; Ola E Dahl; Nadia Rosencher; Andreas A Kurth; C Niek van Dijk; Simon P Frostick; Martin H Prins; Rohan Hettiarachchi; Stefan Hantel; Janet Schnee; Harry R Büller Journal: Lancet Date: 2007-09-15 Impact factor: 79.321
Authors: Piotr Kasina; Alexander Wall; Lasse J Lapidus; Ola Rolfson; Johan Kärrholm; Szilard Nemes; Bengt I Eriksson; Maziar Mohaddes Journal: Clin Orthop Relat Res Date: 2019-06 Impact factor: 4.176
Authors: S Müller; T Wilke; M Pfannkuche; I Meber; A Kurth; H Merk; F Steinfeldt; D Ganzer; C Perka Journal: Orthopade Date: 2011-07 Impact factor: 1.087
Authors: Kathrin S Utz; Jana Hoog; Andreas Wentrup; Sebastian Berg; Alexandra Lämmer; Britta Jainsch; Anne Waschbisch; De-Hyung Lee; Ralf A Linker; Thomas Schenk Journal: Ther Adv Neurol Disord Date: 2014-11 Impact factor: 6.570
Authors: Brett T Venker; Beejal R Ganti; Hannah Lin; Elizabeth D Lee; Ryan M Nunley; Brian F Gage Journal: J Arthroplasty Date: 2016-10-05 Impact factor: 4.757
Authors: Andréa Senay; Milanne Trottier; Josée Delisle; Andreea Banica; Benoit Benoit; G Yves Laflamme; Michel Malo; Hai Nguyen; Pierre Ranger; Julio C Fernandes Journal: Vasc Health Risk Manag Date: 2018-05-08
Authors: M Najafzadeh; S C Kim; C Patterson; S Schneeweiss; J N Katz; G W Brick; J E Ready; J M Polinski; E Patorno Journal: BMC Musculoskelet Disord Date: 2015-10-26 Impact factor: 2.362